AstraZeneca signs partnership of Foxiga and Xigduo with Daewoong Pharmaceutical

Published: 2018-03-05 15:29:40

Updated: 2018-03-05 15:29:40

AstraZeneca Korea(CEO/President Sang-Pyo Kim) announced the company established a distribution partnership of ‘Forxiga(dapagliflozin)’ and ‘Xigduo(dapagliflozin/metformin),’ SGLT-2 inhibitors for the treatment of hepatitis type 2, with Daewoong Pharmaceutical(CEO Jong-Wook Lee).

Therefore, Daewoong Pharmaceutical will manage distribution of the two products in Korea from 1 March. The two compa...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.